Suppr超能文献

尼日利亚西南部伊莱-伊费地区患者幽门螺杆菌的抗生素耐药性

Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria.

作者信息

Aboderin Oladiipo A, Abdu Abdul R, Odetoyin Babatunde 'Wumi, Okeke Iruka N, Lawal Oladejo O, Ndububa Dennis A, Agbakwuru Augustine E, Lamikanra Adebayo

机构信息

Department of Medical Microbiology & Parasitology, Faculty of Basic Medical Sciences, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.

出版信息

Afr Health Sci. 2007 Sep;7(3):143-7. doi: 10.5555/afhs.2007.7.3.143.

Abstract

BACKGROUND

Helicobacter pylori has become recognized as a major cause of gastroduodenal diseases in man. Evidence indicates that once acquired, H. pylori persists, usually for life unless eradicated by antimicrobial therapy. Over the past few years, we have accumulated some knowledge of the epidemiology of H. pylori in Ile-Ife, South-West Nigeria. In one collaborative study, we detected H. pylori in 195 (73%) patients referred for endoscopy at Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC). Furthermore we have observed a variegated gastric inflammatory response and atrophy including atrophic pangastritis but are yet to demonstrate MALToma in any of our patients. In addition we have demonstrated that dental plaque is a possible source of gastric H. pylori infection and such an endogenous source could account for difficulty in eradication leading to re-infection. Presently, infected patients are treated with standard combination therapy made up of amoxycilin and ciprofloxacin with a proton pump inhibitor/bismuth. Reports however have shown that the incidence of antimicrobial resistance in Helicobacter pylori is a growing problem and which has been linked with failures in treatment and eradication. Given this situation it has become necessary to have information about the susceptibility of isolates to particular antimicrobial agents before the selection of an appropriate treatment regimen.

OBJECTIVES

More recently, we sought to study antimicrobial susceptibility of locally isolated H. pylori strains.

METHODS

We subjected 32 isolates to antimicrobial susceptibility testing against seven agents.

RESULTS

All the isolates showed multiple acquired antimicrobial resistance as they were all resistant to amoxicillin, clarithromycin, metronidazole, while 29/31, 27/31 showed resistance to rifampicin and tetracycline respectively. Five (15.6%) of these isolates showed resistance to ciprofloxacin.

CONCLUSIONS

Our findings suggest that H. pylori strains isolated within our study environment have acquired resistance to all the commonly prescribed antibiotics. On the basis of the findings it would be necessary to re-evaluate the eradication treatment regime in our setting.

摘要

背景

幽门螺杆菌已被公认为人类胃十二指肠疾病的主要病因。有证据表明,一旦感染幽门螺杆菌,若不通过抗菌治疗根除,通常会终身携带。在过去几年里,我们积累了一些关于尼日利亚西南部伊莱-伊费地区幽门螺杆菌流行病学的知识。在一项合作研究中,我们在奥巴费米·阿沃洛沃大学教学医院综合院区(OAUTHC)接受内镜检查的195名患者(73%)中检测到了幽门螺杆菌。此外,我们观察到了多样化的胃炎反应和萎缩,包括萎缩性全胃炎,但尚未在任何患者中发现黏膜相关淋巴组织淋巴瘤。此外,我们已经证明牙菌斑可能是胃幽门螺杆菌感染的一个来源,这种内源性来源可能是导致根除困难和再感染的原因。目前,感染患者接受由阿莫西林、环丙沙星与质子泵抑制剂/铋组成的标准联合治疗。然而,报告显示幽门螺杆菌对抗菌药物的耐药率不断上升,这与治疗和根除失败有关。鉴于这种情况,在选择合适的治疗方案之前,有必要了解分离株对特定抗菌药物的敏感性。

目的

最近,我们试图研究本地分离的幽门螺杆菌菌株的抗菌药物敏感性。

方法

我们对32株分离株进行了针对7种药物的抗菌药物敏感性测试。

结果

所有分离株均表现出多重获得性抗菌药物耐药性,因为它们均对阿莫西林、克拉霉素、甲硝唑耐药,而分别有29/31、27/31对利福平和四环素耐药。其中5株(15.6%)对环丙沙星耐药。

结论

我们的研究结果表明,在我们的研究环境中分离出的幽门螺杆菌菌株已对所有常用处方抗生素产生耐药性。基于这些发现,有必要重新评估我们这里的根除治疗方案。

相似文献

1
Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria.
Afr Health Sci. 2007 Sep;7(3):143-7. doi: 10.5555/afhs.2007.7.3.143.
3
Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat.
Indian J Med Microbiol. 2014 Oct-Dec;32(4):408-13. doi: 10.4103/0255-0857.142256.
5
Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea.
J Clin Gastroenterol. 2006 Sep;40(8):683-7. doi: 10.1097/00004836-200609000-00004.
6
ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOBÍO REGION (CHILE) IN A DECADE.
Arq Gastroenterol. 2019 Oct-Dec;56(4):361-366. doi: 10.1590/S0004-2803.201900000-72.

引用本文的文献

1
Clarithromycin-resistant Helicobacter pylori in Africa: a systematic review and meta-analysis.
Antimicrob Resist Infect Control. 2025 Apr 12;14(1):31. doi: 10.1186/s13756-025-01533-6.
3
antibiotic sensitivity pattern in dyspeptic patients in Kano, Nigeria.
S Afr J Infect Dis. 2019 Oct 17;34(1):125. doi: 10.4102/sajid.v34i1.125. eCollection 2019.
4
Infections with and challenges encountered in Africa.
World J Gastroenterol. 2019 Jul 7;25(25):3183-3195. doi: 10.3748/wjg.v25.i25.3183.
5
Gastroprotective and gastric motility benefits of AD-lico/Healthy Gut™ extract.
Anim Cells Syst (Seoul). 2017 Aug 18;21(4):255-262. doi: 10.1080/19768354.2017.1357660. eCollection 2017.
6
Clinical and Socio- Demographic Risk Factors for Acquisition of Helicobacter pylori Infection in Nigeria.
Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1851-1857. doi: 10.22034/APJCP.2018.19.7.1851.
8
Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profile.
PLoS One. 2017 May 2;12(5):e0176454. doi: 10.1371/journal.pone.0176454. eCollection 2017.
9

本文引用的文献

1
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
Gut. 2007 Jun;56(6):772-81. doi: 10.1136/gut.2006.101634. Epub 2006 Dec 14.
2
Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
Antimicrob Agents Chemother. 2005 Aug;49(8):3468-73. doi: 10.1128/AAC.49.8.3468-3473.2005.
3
H pylori antibiotic resistance: prevalence, importance, and advances in testing.
Gut. 2004 Sep;53(9):1374-84. doi: 10.1136/gut.2003.022111.
6
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Aliment Pharmacol Ther. 2002 Feb;16(2):167-80. doi: 10.1046/j.1365-2036.2002.01169.x.
7
Antibiotic resistance of Helicobacter pylori strains in Japanese children.
J Clin Microbiol. 2002 Feb;40(2):649-53. doi: 10.1128/JCM.40.2.649-653.2002.
8
Metronidazole resistance in Helicobacter pylori.
Int J Antimicrob Agents. 2002 Jan;19(1):1-7. doi: 10.1016/s0924-8579(01)00468-x.
9
European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori.
Eur J Clin Microbiol Infect Dis. 2001 Nov;20(11):820-3. doi: 10.1007/s100960100611.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验